Table 2 The crude incidence rate of malignancies in patients with SLE

Overall malignancies

836

138.16 (128.79, 147.52)

738

134.45 (124.75, 144.15)

98

174.40 (139.87, 208.93)

Solid malignancy

768

126.92 (117.94, 135.90)

686

124.97 (115.62, 134.33)

82

145.93 (114.34, 177.51)

 Breast and reproductive system

175

28.92 (24.64, 33.21)

164

29.88 (25.30, 34.45)

11

19.58 (8.01, 31.14)

 Thyroid

154

25.45 (21.43, 29.47)

148

26.96 (22.62, 31.31)

6

10.68 (2.13, 19.22)

 Liver

63

10.41 (7.84, 12.98)

55

10.02 (7.37, 12.67)

8

14.24 (4.37, 24.10)

 Colon

61

10.08 (7.55, 12.61)

51

9.29 (6.74, 11.84)

10

17.80 (6.77, 28.83)

 Lung

34

5.62 (3.73, 7.51)

25

4.55 (2.77, 6.34)

9

16.02 (5.55, 26.48)

 Pancreas

32

5.29 (3.46, 7.12)

29

5.28 (3.36, 7.21)

3

5.34 (0, 11.38)

 Stomach

31

5.12 (3.32, 6.93)

27

4.92 (3.06, 6.77)

4

7.12 (0.14, 14.09)

 Bladder

12

1.98 (0.86, 3.11)

10

1.82 (0.69, 2.95)

2

3.56 (0, 8.49)

 Head and neck

11

1.82 (0.74, 2.89)

9

1.64 (0.57, 2.71)

2

3.56 (0, 8.49)

 Kidney

10

1.65 (0.63, 2.68)

5

0.91 (0.11, 1.71)

5

8.90 (1.10, 16.70)

 Biliary tract

7

1.16 (0.30, 2.01)

4

0.73 (0.01, 1.44)

3

5.34 (0, 11.38)

 Brain and central nervous system

5

0.83 (0.10, 1.55)

5

0.91 (0.11, 1.71)

0

NC

 Larynx

2

0.33 (0, 0.79)

2

0.36 (0, 0.87)

0

NC

Haematology malignancy

68

11.24 (8.57, 13.91)

52

9.47 (6.90, 12.05)

16

28.47 (14.52, 42.43)

 Non-Hodgkin lymphoma

36

5.95 (4.01, 7.89)

27

4.92 (3.06, 6.77)

9

16.02 (5.55, 26.48)

 Multiple myeloma

14

2.31 (1.10, 3.53)

13

2.37 (1.08, 3.66)

1

1.78 (0, 5.27)

 Leukaemia

12

1.98 (0.86, 3.11)

8

1.46 (0.45, 2.47)

4

7.12 (0.14, 14.09)

 Hodgkin lymphoma

3

0.50 (0, 1.06)

3

0.55 (0, 1.16)

0

NC